|
|||||
OcufloxActive Ingredient(s): OfloxacinFirst Approved by the FDA: July 30, 1993 Pharmaceutical Company: ALLERGAN Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to OcufloxDrops 0.3% Injection 20mg/ml, 40mg/ml Solution 0.3% Solution/drops 0.3% Tablet 200mg, 300mg, 400mg Related Drug Page(s):Other Drugs Containing Ofloxacin or a Similar Compund: Related Search Results for OcufloxWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Ocuflox Text Link HTML Code: Related: Ocuflox care classification about, pills detailed class locate Ocuflox, answers what is about druggist withdrawal Ocuflox, Ocuflox schedule foreign foreign, Ocuflox precautions dose drugs news description, Ocuflox talk online identify coverage, Ocuflox facts effective definition pharmacology efficacy, industry Ocuflox, manufacturer medication alternative detailed medicine Ocuflox, institute druggist consultation almanac Ocuflox. discuss drug pharma Ofloxacin, drugs ingredients guide Ofloxacin, precautions capsule condition addiction policy Ofloxacin, doctor Ofloxacin, Ofloxacin book, instructions Ofloxacin. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Ocuflox.asp Last Updated June 27 2005 |
|||||